ScyFIX

ScyFIX seeks to raise $4M for device to treat degenerative eye disease

ScyFIX is seeking to raise $4 million as the Chanhassen, Minnesota-based company continues to seek U.S. Food and Drug Administration approval for a device that uses slight electric shocks to treat degenerative eye disease. ScyFIX has just started the offering, which expires in June 2012, according to a recent U.S. Securities and Exchange Commission filing. […]

Devices & Diagnostics

Acuity Medical raises $1.5M for macular degeneration device

Acuity is developing neurostimulation technology to treat dry macular degeneration, a chronic eye disease that primarily affects older patients, causing blurred vision and even blindness in central vision.

By Thomas Lee

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.